Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
TerminatedNCT00539188
NAC Addition to Dialectical Behavioral Therapy for Borderline Personality Disorder; Self-Injurious Behavior
This study was terminated in the United States. It is testing NAC Addition to Dialectical Behavioral Therapy for Borderline Personality Disorder; Self-Injurious Behavior.
Personality disorders, Borderline personality, ...DrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateSeptember 2007
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 6
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00539188
- Official title
- A Double-Blind, Placebo-controlled Pilot Study of NAC Addition to Dialectical Behavioral Therapy for the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00539188. We help you review the study, but cannot decide medical eligibility.
Recruitment & locations
TerminatedNew Haven
Registry details
Registry conditions (original wording)
Borderline Personality Disorder; Self-Injurious Behavior
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including N-Acetylcysteine and placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
TerminatedNCT02149823
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
This study has public registry information. It focuses on personality disorders and currently lists study information in the United States.
TerminatedNCT03395314
Ketamine in Borderline Personality Disorder
This study has public registry information. It focuses on personality disorders and currently lists study information in the United States.
TerminatedNCT00353379
Pharmacology of Cognition in Schizotypal Personality Disorder
This study has public registry information. It focuses on personality disorders and currently lists study information in the United States.